Relay Therapeutics, Inc. (RLAY) Capital expenditures 2019–2025
Relay Therapeutics, Inc. (RLAY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$410,000FY2025 · since FY2019: $8.0M → $410,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $410,000 | -79.7% |
| FY2024 | $2.0M | -51.1% |
| FY2023 | $4.1M | -54.5% |
| FY2022 | $9.1M | +161.1% |
| FY2021 | $3.5M | +79.8% |
| FY2020 | $1.9M | -75.9% |
| FY2019 | $8.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice